It has been six months since the Johnson & Johnson vaccine received emergency use authorization. What does six months of data show about its efficacy, side effects and protection from variants?
Rigor acadêmico, estilo jornalístico
Todos os artigos de Booster shot
Exibindo 21 - 21 de 21 artigo
Principais colaboradores
-
Canada Research Chair in Aging & Immunity, McMaster University
-
Associate Professor of Biology, Rochester Institute of Technology
-
Professor of Medicine, Pathology & Laboratory Medicine, and Epidemiology & Biostatistics, Western University
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Henry Baldwin Professorial Research Fellow in Health System Sustainability, University of Tasmania
-
Associate Professor of Medicine and Geriatrics, University of Virginia
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Public Health, American University
-
Postdoctoral fellow, McGill University
-
Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Senior Research Officer, National Centre for Immunisation Research and Surveillance; PhD candidate, Australian National University
-
Professor of Behavioural Medicine, Concordia University
-
Postdoctoral Fellow in Epidemiology, University of North Carolina at Chapel Hill
